Kahn Brothers Group’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Kahn Brothers Group's OGN Position: Q2 2026 in Review
Kahn Brothers Group reduced its Organon & Co (OGN) stake by 52% in Q2 2026, selling an estimated $34.3M and leaving 2,670,523 shares worth $36.2M. The position accounts for 5.72% of the portfolio, ranked #6.
Kahn Brothers Group first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $38.6M in Q3 2025. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Kahn Brothers Group held 2,670,523 shares of Organon & Co worth $36.2M as of Q2 2026.
- Kahn Brothers Group sold 2,866,470 Organon & Co shares in Q2 2026, an estimated $34.3M.
- Organon & Co made up 5.72% of Kahn Brothers Group's portfolio in Q2 2026, its #6 holding.
- Kahn Brothers Group first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
- Kahn Brothers Group's Organon & Co position peaked at $38.6M in Q3 2025.
- 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Kahn Brothers Group's 13F filing for Q2 2026, filed 14 Aug 2026.